Regulatory Focus™ > News Articles > South Korean Regulators Increase Online Data Transparency

South Korean Regulators Increase Online Data Transparency

Posted 31 May 2012 | By

South Korea's Korean Food and Drug Administration (KFDA) has announced the re-launch of its website, which now includes consolidated drug information covering all drugs manufactured in South Korea.

The website now features a sub-page, drug.kfda.go.kr, which allows for the public to "retrieve and utilize a variety of drug information," including drug safety, drug effects, drug development assistance, information on pharmaceutical excipients, drug use and more. Additional information covers whether a product is KFDA-approved or covered by Korea's health insurers.

KFDA said the website renovation was part of its "efforts to more actively promote safe and effective use of medications by enabling easier access of the public to drug related information including its side-effects, recommended dosage and special precautions."


Read more:

KFDA - Newly renovated website brings in information service on domestically produced drugs

KFDA - drug.kfda.go.kr


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe